Immunotherapy in Turkey typically costs from AUD $3,109 to AUD $7,632 for initial treatment cycles. Final prices depend on the specific drug protocol, cancer type, and diagnostic requirements like PD-L1 testing. Patients save about 62% compared to Australia, where average costs reach AUD $13,992. Packages often include oncologist consultations, airport transfers, and personal coordination services.
Bookimed Expert Insight: Australian patients gain access to US-standard protocols through strategic partnerships. Anadolu Medical Center, for example, collaborates with Johns Hopkins Medicine Institute. This provides high-tier care at lower costs. Specialist doctors like Professor Necdet Uskent have 50+ years of experience. Some clinics even offer air ambulance services. This infrastructure supports complex cases that face long waitlists back home.
| Turkey | Thailand | South Korea | |
| Immunotherapy | from AUD $3,109 | from AUD $28,268 | from AUD $6,360 |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $4,664 | from AUD $11,307 | from AUD $7,350 |
| Sarcoma Immunotherapy | from AUD $25,441 | from AUD $35,334 | - |
| Immunotherapy for prostate cancer | from AUD $16,961 | from AUD $63,602 | - |
| Immunotherapy for lung cancer | from AUD $25,441 | from AUD $35,334 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
The doctor is a highly experienced Turkish medical oncologist specializing in sarcoma, lymphoma, pancreatic, lung cancer, and breast cancer. With over 20 years of experience, the doctor focuses on tumor biology, tumor immunology, cancer immunotherapy, and targeted therapies. Since 2019, the doctor has been serving as a medical oncologist at Anadolu Medical Center and previously held leadership roles at Istanbul Okan University Faculty of Medicine and GATA Haydarpaşa Training Hospital. The doctor has authored over 40 publications in cancer research and is a member of the Turkish Medical Oncology Association and the European Head and Neck Society.
Professor Zafer Gülbaş — hematologist-oncologist, founder and director of the Bone Marrow Transplant Center at Anadolu Medical Center, which is among the largest in Europe.
Why patients choose and trust Dr. Gülbaş:
The doctor is a highly regarded oncologist at the Anadolu Medical Center, specializing in medical oncology and chemotherapy. After obtaining a medical degree from Ankara University in 2005, the doctor completed specialty training in internal medicine at Istanbul University and further specialized in medical oncology at Marmara University by 2017. The doctor has led the medical oncology unit at Haydarpaşa Numune Training and Research Hospital and has participated in numerous international clinical studies. The doctor focuses on a wide range of cancers, including breast, urological, lung, and gastrointestinal cancers, among others.
The doctor is a member of several prestigious oncology societies, including the Turkish Society of Medical Oncology, the European Society of Medical Oncology, and the American Society of Medical Oncology. The doctor has participated in advanced training programs globally, including programs at Oxford University and ESMO.
The doctor graduated from the School of Medicine at Hacettepe University and completed residency at Istanbul Sisli Etfal Training and Research Hospital, followed by a fellowship at the Hacettepe University Cancer Institute.
Specializing in oncology, the doctor has extensive experience in treating various cancers, including breast, testicular, ovarian, lung, head and neck, and gastrointestinal cancers.
The doctor has worked at prestigious institutions such as The University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.